Glenmark Q2 Profit Falls 56.8% on Lower North America Sales
Glenmark Pharmaceuticals reported consolidated net profit of 2.64 billion rupees for the quarter ended September 30, down 56.8% as North America revenue fell.
India's Glenmark Pharmaceuticals NSE:GLENMARK posted a 56.8% drop in second-quarter profit on Thursday, weighed down by lower revenue from its North American business.The company reported a consolidated net profit of 2.64 billion rupees ($27.93 million) for the quarter ended September 30, compared…